Screener
Immunovant, Inc. IMVT United States — Total loss before income taxes
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The source filing: Immunovant, Inc.’s 10-K, filed May 20, 2026.
- Filed
- May 20, 2026, 7:28 AM EDT
- Fiscal year
- FY2026
- Accession
- 0001764013-26-000064
| Line item | Years Ended March 31, 2026 | Years Ended March 31, 2025 | Years Ended March 31, 2024 |
|---|---|---|---|
| (Loss) income before income taxes | |||
| United States | $100,991 | $(17,730) | $(16,180) |
| Switzerland | (606,288) | (395,119) | (242,518) |
| Bermuda | (39) | (100) | (71) |
| United Kingdom | (55) | — | — |
| Total loss before income taxes | $(505,391) | $(412,949) | $(258,769) |
| Current taxes | |||
| United States – Federal | — | $880 | $562 |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Immunovant, Inc.'s united states — total loss before income taxes?
- Immunovant, Inc. (IMVT) reported united states — total loss before income taxes of $25.25M in Q1 2026.
- How has Immunovant, Inc.'s united states — total loss before income taxes changed year-over-year?
- Immunovant, Inc.'s united states — total loss before income taxes increased by 669.6% year-over-year, from -$4.43M to $25.25M.
- What is the long-term trend for Immunovant, Inc.'s united states — total loss before income taxes?
- Over 4 years (2022 to 2026), Immunovant, Inc.'s united states — total loss before income taxes has grown at a 23.1% compound annual growth rate (CAGR), from -$43.95M to $100.99M.
- What does united states — total loss before income taxes mean?
- Represents the total pre-tax financial loss generated by operations within the United States geographic segment. This metric highlights the profitability profile of the company's domestic activities before accounting for income tax expenses or benefits. It is a key indicator of the underlying operational performance of the domestic business unit.
Ask your AI about Immunovant, Inc.'s united states — total loss before income taxes.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude